Anges Inc.

Anges Inc. is a biotechnology company distinguished for its contributions to advanced genetic medicine research. The company's primary focus lies in the development of DNA-based therapies, which aim to address critical needs in various medical fields, including cardiovascular diseases, infectious diseases, and oncology. Notable for its pioneering work in gene therapy and novel vaccines, Anges Inc. seeks to harness the potential of DNA to produce therapeutic and preventive solutions. As a prominent player in the biotech sector, Anges maintains collaborations with academic institutions and pharmaceutical companies to further its research and development efforts. Headquartered in Japan, the company holds a significant role in the market by advancing medical innovation and driving progress in personalized medicine. Through its innovative pipeline and clinical trials, Anges Inc. is poised to influence healthcare outcomes, offering new hope for patients with conditions that lack effective treatments.